Windlas Biotech Limited (WINDLAS) — Capital Reinvestment Ratio
Latest as of March 2025:
0.77x
Windlas Biotech Limited (WINDLAS) has a Capital Reinvestment Ratio of 0.77x as of March 2025, meaning it reinvests 1% of its operating cash flow (Rs681.87 Million) in capital expenditures (Rs521.94 Million). See WINDLAS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.77x
Capex / Operating Cash Flow
Operating Cash Flow
Rs681.87 Million
INR
Capital Expenditures
Rs521.94 Million
INR
Data as of
Mar 2025
Most recent filing
Windlas Biotech Limited Capital Reinvestment Ratio (2018–2025)
This chart tracks Windlas Biotech Limited's Capital Reinvestment Ratio across 8 annual periods.
Annual Capital Reinvestment Ratio for Windlas Biotech Limited (2018–2025)
Year-by-year Capital Reinvestment Ratio for Windlas Biotech Limited from 2018 to 2025. For live market cap and broader valuation context, see Windlas Biotech Limited market capitalisation.
| Year | Reinvestment Ratio | Operating CF (INR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.77x | Rs681.87 Million | Rs521.94 Million | ▲ +121.3% |
| 2024 | 0.35x | Rs1.09 Billion | Rs376.84 Million | ▼ -70.3% |
| 2023 | 1.16x | Rs609.65 Million | Rs708.90 Million | ▼ -28.3% |
| 2022 | 1.62x | Rs91.30 Million | Rs148.04 Million | ▲ +217.6% |
| 2021 | 0.51x | Rs114.54 Million | Rs58.47 Million | ▼ -16.6% |
| 2020 | 0.61x | Rs250.06 Million | Rs153.10 Million | ▲ +27.6% |
| 2019 | 0.48x | Rs186.54 Million | Rs89.54 Million | ▼ -44.9% |
| 2018 | 0.87x | Rs295.91 Million | Rs257.82 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow